Krystal BiotechFRA:4KB +4.12%58 Days Inventory is 596.00 as of Mar. 2026, which is 12% above its 10-year median of 530.37. GuruFocus rates FRA:4KB with a GF Score™ of 58/100 and a GF Value™ of €269.18 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 638 Biotechnology companies, Krystal Biotech ranks worse than 82.92% on this metric.
The historical rank and industry rank for Krystal Biotech's Days Inventory or its related term are showing as below:
FRA:4KB'
s Days Inventory Range Over the Past 10 Years
Min: 304.69 Med: 530.37 Max: 824.02
Current: 544.99
During the past 10 years, Krystal Biotech's highest Days Inventory was 824.02. The lowest was 304.69. And the median was 530.37.
FRA:4KB's Days Inventory is ranked worse than 82.92% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs FRA:4KB: 544.99
Krystal Biotech's Days Inventory
increased
from Mar. 2025 (520.02) to Mar. 2026 (596.00).
It might indicate that Krystal Biotech's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Krystal Biotech's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.15.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Krystal Biotech's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.35.
Krystal Biotech (FRA:4KB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Krystal Biotech's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Krystal Biotech's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Krystal Biotech Days Inventory Related Terms
Krystal Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Krystal Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:4KB vs TECH, SMMT, ARWR: Days Inventory Comparison
For the Biotechnology subindustry, Krystal Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krystal Biotech Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Krystal Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Krystal Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krystal Biotech (FRA:4KB) has a Days Inventory of 596.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Krystal Biotech and its competitors. This is 12% above median its historical median of 530.37. Over the past decade, Krystal Biotech's Days Inventory has ranged from 304.69 to 824.02. According to the industry distribution chart, Krystal Biotech ranks #529 out of 638 companies in the Biotechnology industry, placing it in the top 82.9%.
Is Krystal Biotech's Days Inventory too high?
Krystal Biotech's current Days Inventory of 596.00 is 12% above median its 10-year median of 530.37. Over the past 10 years, this metric has ranged from a low of 304.69 to a high of 824.02. The Biotechnology industry median Days Inventory is 183.88. Krystal Biotech's value of 596.00 is 224.1% above this industry median. Based on the distribution chart, Krystal Biotech ranks #529 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Krystal Biotech has a GF Score™ of 58/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krystal Biotech's Days Inventory compare to TECH and SMMT?
According to the Biotechnology industry distribution chart, Krystal Biotech ranks #529 out of 638 companies for Days Inventory. This places Krystal Biotech in the lower half of its industry. The industry median Days Inventory is 183.88. Krystal Biotech's value of 596.00 is 224.1% above this benchmark. Historically, Krystal Biotech's own Days Inventory has ranged from 304.69 to 824.02 over the past decade. While the company's 10-year median is 530.37 vs. the industry median of 183.88, Krystal Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krystal Biotech's current Days Inventory of 596.00 is 224.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Krystal Biotech and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krystal Biotech's current Days Inventory is 596.00, which is 12% above median its own 10-year median of 530.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krystal Biotech stock overvalued right now?
Based on GuruFocus' analysis, Krystal Biotech (FRA:4KB) is currently considered Modestly Overvalued. The stock's GF Value™ is €269.18, compared to a current price of €326.30 — trading 21.2% above its estimated fair value. The current Days Inventory is 596.00, which is 12% above median its 10-year median of 530.37 and 224.1% above the Biotechnology industry median of 183.88. Krystal Biotech's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Krystal Biotech (FRA:4KB), the current Days Inventory is 596.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krystal Biotech (FRA:4KB) Overvalued in 2026?
Based on GuruFocus' analysis, Krystal Biotech stock appears to be overvalued.
The current stock price of €326.30 is trading 21.2% above its estimated GF Value™ of €269.18.
GuruFocus considers Krystal Biotech to be Modestly Overvalued.
Key valuation signals for FRA:4KB:
Days Inventory: 596.00 (12% above median its 10-year median of 530.37)
GF Value™: €269.18 vs. price of €326.30 (21.2% above fair value)
Industry Position: 224.1% above the Biotechnology median (#529 of 638)
No single metric tells the full story. See the FRA:4KB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
58GF Score
Get the complete analysis for FRA:4KB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4KB has been successfully added to your 
